In fact, CKD stage 3 (GFR 30–59 ml/min/1.73 m 2) comprises 45–80% of the CKD population and 7–10% of general population. 3,4,5 In individuals with eGFR 50–59 ml/min/1.73 m 2 the risk of ...

The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...

Objective: Patients with chronic kidney disease (CKD) are at higher risk for cardiovascular disease (CVD) than patients in the general population. One potentially modifiable risk factor for CVD in ...

Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.

Weight cycling is a pattern in which individuals repeatedly lose and regain body weight. Researchers have found in a new ...

It is intended as a therapy that stabilizes kidneys, making it potentially useful for CKD patients ... If, for instance, the eGFR suggests the treatment is indeed effective, the FDA might grant ...

The risks for disease progression and death were lower for patients with stage 3b or higher CKD receiving GLP ... Their baseline estimated glomerular filtration rate (eGFR) was less than 45 ...

Body weight cycling in type 1 diabetes is associated with increased risk of chronic kidney disease. Maintaining stable weight ...

Starting SGLT2 inhibitors led to a lower risk for eGFR decline or incident kidney ... medicine clinics with no history of CKD; 50 patients with CKD stages 3 through 4 from nephrology outpatient ...

The study enrolled 3533 participants with T2D and CKD (defined as eGFR 25 to 75mL/min/1.73m 2 and urinary albumin-to-creatinine ratio [UACR] >100 and <5000mg/g). Study participants were randomly ...

In keeping with current guidelines, either empagliflozin or dapagliflozin can be used for preventing AKI and CKD in patients with type 2 ... hemoglobin A1c level, estimated glomerular filtration rate ...